Efficacy of high-titer live attenuated varicella vaccine in healthy young children

Journal of Infectious Diseases

Volumn 174, Issue SUPPL. 3, 1996, Pages

  Varis, Tiina ^a   Vesikari, Timo ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ANTIBODY TITER; ARTICLE; CHICKENPOX; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOGENICITY; INFANT; INFECTION PREVENTION; MALE; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

EID: 0029859658     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.supplement_3.s330     Document Type: Article

References (23)

1. Takahashi M, Otsuka T, Okuno Y, et al. Live attenuated varicella vaccine used to prevent the spread of varicella in hospital. Lancet 1974;2:1288-90.
2. Izawa T, Ihara T, Hattori A, et al. Application of a live varicella vaccine in children with acute leukemia or other malignant disease. Pediatrics 1977; 60:805-9.
3. Brunell PA, Shehab Z, Geiser C, Waugh JE. Administration of live varicella vaccine to children with leukemia. Lancet 1982; 2:1069-72.
4. Gershon A, Steinberg S, Gelb L, et al. Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 1984; 252:355-62.
5. Gershon A, Steinberg S, Gelb L, et al. Use of live attenuated varicella in immunocompromised children and adults. Pediatrics 1986;78:757-62.
6. Gershon A, Steinberg S, NIAID Varicella Vaccine Collaborative Study Group. Persistence of immunity to varicella vaccine with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 1989; 320:892-7.
7. Arbeter AM, Starr SE, Weibel RE, et al. Live attenuated varicella vaccine: immunization of healthy children with the Oka strain. Pediatrics 1982; 100:886-93.
8. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine: efficacy trial in healthy children. N Engl J Med 1984;310:1409-15.
9. Johnson JE, Shurin PA, Flattlar D, et al. Live attenuated varicella vaccine in healthy 12- to 24-month-old children. Pediatrics 1988;81:512-8.
10. Vesikari T, Öhrling A, Baer M, et al. Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children. Acta Paediatr Scand 1991;80:1051-7.
11. White CJ, Kuter B, Ngai A, et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J 1992;11:19-23.
12. Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991;9:643-7.
13. Watson BA, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993;91:17-22.
14. Williams V, Gershon A, Brunell P. Serological response to varicella-zoster membrane antigens measured by indirect immunofluorescence. J Infect Dis 1974; 134:669-72.
15. Gershon A. Viral vaccines of the future. Pediatr Clin North Am 1990; 37: 892-7.
16. Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy. Pediatrics 1987;80:465-72.
17. Asano Y, Nagai T, Miyota T, et al. Long-term protective immunity of recipients of the Oka strain of live varicella virus vaccine. Pediatrics 1985; 75:667-71.
18. Kamiya H, Sakurai M, Ihara T, et al. Clinical use of Oka live varicella vaccine. Acta Paediatr Jpn 1988;30:594-600.
19. Clements DA, Maggio MV, Ursano AM, Wilfert CM. Safety, immunogenicity and 5-year efficacy of Oka/Merck varicella vaccine in normal infants and adolescents. Pediatr Res 1993;33:165A.
20. Watson B, Piercy S, Soppas D, et al. The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine. J Infect Dis 1993; 168:1356-60.
21. Jackson MA, Burry F, Oison LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 1992; 11:441-5.
22. Preblud SR, Orenstein WA, Koplan JP, Bart KJ, Hinman AR. A benefitcost analysis of a childhood varicella vaccination program. Postgrad Med J 1985;61(suppl 4):17-22.
23. Preblud SR. Varicella: complications and costs. Pediatrics 1986; 78:728-35.